Axogen, Inc. Operating Lease, Lease Income, Lease Payments
Axogen, Inc. (AXGN) reported Operating Lease, Lease Income, Lease Payments of $1.54 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Income Statement › Other Income
us-gaap:OperatingLeaseLeaseIncomeLeasePayments · last filed 2022-02-25
- Axogen, Inc. operating lease, lease income, lease payments for the quarter ending 2021-12-31 was $420.00K, a 18.29% decline year-over-year.
- Axogen, Inc. operating lease, lease income, lease payments for the quarter ending 2021-09-30 was $295.00K, a 39.05% decline year-over-year.
- Axogen, Inc. operating lease, lease income, lease payments for the quarter ending 2021-06-30 was $411.00K, a 0.49% increase year-over-year.
- Axogen, Inc. operating lease, lease income, lease payments for the quarter ending 2021-03-31 was $411.00K, a 18.77% decline year-over-year.
- Axogen, Inc. operating lease, lease income, lease payments for fiscal 2021 was $1.54M, a 19.65% decline from fiscal 2020.
- Axogen, Inc. operating lease, lease income, lease payments for fiscal 2020 was $1.91M, a 7.90% increase from fiscal 2019.
- Axogen, Inc. operating lease, lease income, lease payments for fiscal 2019 was $1.77M.
| Period end | Operating Lease, Lease Income, Lease Payments 3 month | Operating Lease, Lease Income, Lease Payments 6 month | Operating Lease, Lease Income, Lease Payments 9 month | Operating Lease, Lease Income, Lease Payments 12 month |
|---|---|---|---|---|
| 2021-12-31 | $420.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $715.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.13M derived: sum of 3 quarters · filed 2022-02-25 | $1.54M 10-K · filed 2022-02-25 |
| 2021-09-30 | $295.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $706.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.12M 10-Q · filed 2021-11-04 | $1.63M derived: sum of 4 quarters · filed 2022-02-25 |
| 2021-06-30 | $411.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $822.00K 10-Q · filed 2021-08-05 | $1.34M derived: sum of 3 quarters · filed 2022-02-25 | $1.82M derived: sum of 4 quarters · filed 2022-02-25 |
| 2021-03-31 | $411.00K 10-Q · filed 2021-05-06 | $925.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.41M derived: sum of 3 quarters · filed 2022-02-25 | $1.82M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-12-31 | $514.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $998.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.41M derived: sum of 3 quarters · filed 2022-02-25 | $1.91M 10-K · filed 2022-02-25 |
| 2020-09-30 | $484.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $893.00K derived: sum of 2 quarters · filed 2021-11-04 | $1.40M 10-Q · filed 2021-11-04 | $1.86M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $409.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $915.00K 10-Q · filed 2021-08-05 | $1.37M derived: sum of 3 quarters · filed 2021-08-05 | $1.74M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $506.00K 10-Q · filed 2021-05-06 | $965.00K derived: sum of 2 quarters · filed 2021-05-06 | $1.33M derived: sum of 3 quarters · filed 2021-05-06 | $1.80M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $824.00K derived: sum of 2 quarters · filed 2021-03-01 | $1.30M derived: sum of 3 quarters · filed 2021-03-01 | $1.77M 10-K · filed 2021-03-01 |
| 2019-09-30 | $365.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $837.00K derived: sum of 2 quarters · filed 2020-10-30 | $1.31M 10-Q · filed 2020-10-30 | |
| 2019-06-30 | $472.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $949.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $477.00K 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |